The global angioplasty balloons market size reached US$ 2.4 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.25% during 2023-2032.
Angioplasty balloons refer to the medical devices that are used for unblocking and widening clogged blood vessels during surgical procedures. Some of the common types of angioplasty balloons include drug-eluting, normal, scoring and cutting balloons. They are usually manufactured using nylon, polyurethane and silicone urethane polymers and consist of nitinol constraining structures that create grooves and pillows on the surface of the balloon to offer predictable, uniform and atraumatic dilation. During the surgery, the balloon is inflated to flatten the plaque against the wall of the blood vessels, thereby opening them and restoring the normal blood flow.
The increasing prevalence of coronary and periphery artery diseases across the globe is one of the key factors driving the growth of the market. In line with this, the rising geriatric population and individuals suffering from obesity and high levels of cholesterol are also providing a boost to the market growth. Furthermore, there is an increasing preference for drug-coated angioplasty balloons that offer superior safety, effectiveness and improved blood flow throughout the body. This has also reduced the utilization of vessel implants, such as stents, which may cause vessel fracture.
Additionally, various technological advancements, such as the development of imaging technologies, and the advent of innovative variants that can be implanted without administering general anesthesia, are also acting as major growth-inducing factors. Increasing health consciousness among consumers, improving healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences are some of the other factors that are projected to drive the market further.
Angioplasty balloons refer to the medical devices that are used for unblocking and widening clogged blood vessels during surgical procedures. Some of the common types of angioplasty balloons include drug-eluting, normal, scoring and cutting balloons. They are usually manufactured using nylon, polyurethane and silicone urethane polymers and consist of nitinol constraining structures that create grooves and pillows on the surface of the balloon to offer predictable, uniform and atraumatic dilation. During the surgery, the balloon is inflated to flatten the plaque against the wall of the blood vessels, thereby opening them and restoring the normal blood flow.
The increasing prevalence of coronary and periphery artery diseases across the globe is one of the key factors driving the growth of the market. In line with this, the rising geriatric population and individuals suffering from obesity and high levels of cholesterol are also providing a boost to the market growth. Furthermore, there is an increasing preference for drug-coated angioplasty balloons that offer superior safety, effectiveness and improved blood flow throughout the body. This has also reduced the utilization of vessel implants, such as stents, which may cause vessel fracture.
Additionally, various technological advancements, such as the development of imaging technologies, and the advent of innovative variants that can be implanted without administering general anesthesia, are also acting as major growth-inducing factors. Increasing health consciousness among consumers, improving healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences are some of the other factors that are projected to drive the market further.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global angioplasty balloons market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, material and end-user.Breakup by Product Type:
- Normal Balloons
- Cutting Balloons
- Drug Eluting Balloons
- Scoring Balloons
Breakup by Application:
- Coronary Angioplasty
- Peripheral Angioplasty
Breakup by Material:
- Nylon
- Polyurethane
- Silicone Urethane Co-Polymers
- Others
Breakup by End-User:
- Hospitals
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun Melsungen AG, BD (Becton, Dickinson, and Company), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Endocor GmbH & Co. KG, Johnson & Johnson, Medtronic Inc., Terumo Corporation, etc.Key Questions Answered in This Report:
- How has the global angioplasty balloons market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global angioplasty balloons market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the material?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global angioplasty balloons market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Indicators
2 Scope and Methodology
4 Introduction
5 Global Angioplasty Balloons Market
6 Market Breakup by Product Type
7 Market Breakup by Application
8 Market Breakup by Material
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- BD (Becton
- Dickinson
- Company)
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Endocor GmbH & Co. KG
- Johnson & Johnson
- Medtronic Inc.
- Terumo Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 3.2 Billion |
| Compound Annual Growth Rate | 3.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
